(Q71244417)
Statements
The use of azathiaprine and 6-mercaptopurine (6-MP) as immunosuppressive therapy in inflammatory bowel disease and its role in the etiology of lymphocytic lymphoma (English)
Gelb A
scientific article published on 01 May 1983